ScholarIQanswers from OpenAlex
Value in Health Regional Issues
JournalCitation impact & published research
Value in Health Regional Issues is a journal indexed in ScholarIQ from OpenAlex.
How many works does Value in Health Regional Issues have?
ScholarIQindexed works
Value in Health Regional Issues has 2,485 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Value in Health Regional Issues have?
ScholarIQcitation count
Value in Health Regional Issues has 11,861 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Value in Health Regional Issues?
ScholarIQh-index
Value in Health Regional Issues has an h-index of 41 in OpenAlex.
What is the article processing charge of Value in Health Regional Issues?
ScholarIQarticle processing charge
Value in Health Regional Issues lists an article processing charge of 1,500 USD in OpenAlex.
What is the OpenAlex record for Value in Health Regional Issues?
ScholarIQopenalex
The OpenAlex for Value in Health Regional Issues is on the source record.
What are the most-cited papers on Value in Health Regional Issues?
ScholarIQmost cited works
Clinical Characterization and the Caregiver Burden of Dementia in China
Boxiong Tang, Eran Harary, Ricky Kurzman, J Mould-Quevedo, Sharon Pan, Jiyue Yang, Juan Qiao
Prevalence, Awareness, Treatment, and Burden of Major Depressive Disorder: Estimates from the National Health and Wellness Survey in Brazil
Ronaldo Kenzou Fujii, Amir Goren, K. Annunziata, J Mould-Quevedo
Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment
Sachie Inoue, Kōichi Nakao, Michiya Hanyu, Kentaro Hayashida, Hidetoshi Shibahara, Makoto Kobayashi, Miyoshi Asaoka, Kazuhiko Nishikawa, Seth Clancy, Jun Koshiishi, Hiroyuki Sakamaki
Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus in Mexico
C. Neslusan, Anna Teschemaker, Pierre Johansen, Michael Willis, Atanacio Valencia-Mendoza, Andrea Puig
Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b
Phil McEwan, Thomas Ward, Samantha Webster, Yong Yuan, Anupama Kalsekar, Kristine Broglio, Isao Kamae, Melanie Quintana, Scott Berry, Masahiro Kobayashi, Sachie Inoue, Ann Tang, Hiromitsu Kumada